We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-14.34%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.74%
5 Year Est. Return
+136.38%
10 Year Est. Return
+1,412.31%
AUM
$10.3B
AUM Growth
-$797M
Cap. Flow
+$969M
Cap. Flow %
9.41%
Top 10 Hldgs %
9.34%
Holding
3,357
New
810
Increased
937
Reduced
584
Closed
885

Top Buys

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$98M
2
FERG icon
Ferguson
FERG
+$83.1M
3
BAC icon
Bank of America
BAC
+$80.9M
4
BIO icon
Bio-Rad Laboratories Class A
BIO
+$74.4M
5
NKE icon
Nike
NKE
+$63.3M

Top Sells

Rank Stock Value
1
AN icon
AutoNation
AN
+$61.6M
2
BNY
Bank of New York Mellon
BNY
+$51.6M
3
JPM icon
JPMorgan Chase
JPM
+$51.3M
4
PSX icon
Phillips 66
PSX
+$47.7M
5
SPGI icon
S&P Global
SPGI
+$47.5M

Sector Composition

Rank Sector Weight
1 Financials 25.42%
2 Technology 13.52%
3 Industrials 9.35%
4 Healthcare 8.34%
5 Consumer Discretionary 8.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BGRY
2276
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
$29K ﹤0.01%
19,800
+4,500
+29% +$9.94K
AHPI
2277
DELISTED
Allied Healthcare Products
AHPI
$29K ﹤0.01%
17,800
+200
+1% +$454
UP icon
2278
Wheels Up
UP
$198M
$28K ﹤0.01%
72
-146
-67% -$78K
VATE icon
2279
INNOVATE Corp
VATE
$165M
$28K ﹤0.01%
+1,590
New +$43.5K
SYRS
2280
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$28K ﹤0.01%
3,011
+1,501
+99% +$14K
EPZM
2281
DELISTED
Epizyme, Inc
EPZM
$28K ﹤0.01%
18,600
-1,900
-9% -$1.4K
SVM
2282
Silvercorp Metals
SVM
$2.53B
$26K ﹤0.01%
10,600
-530
-5% -$1.6K
AQB icon
2283
AquaBounty Technologies
AQB
$6.02M
$25K ﹤0.01%
+724
New +$22.1K
VHC icon
2284
VirnetX Holding Corp
VHC
$63.1M
$25K ﹤0.01%
1,045
-180
-15% -$5.01K
NAGE
2285
Niagen Bioscience
NAGE
$247M
$25K ﹤0.01%
+15,310
New +$29.9K
BLIN icon
2286
Bridgeline Digital
BLIN
$14.4M
$24K ﹤0.01%
20,400
-500
-2% -$710
PTON icon
2287
Peloton Interactive
PTON
$2.49B
$23K ﹤0.01%
2,500
– –
PTON icon
2288
PUT
Peloton Interactive
PTON
$2.49B
$23K ﹤0.01%
2,500
– –
AWH
2289
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$23K ﹤0.01%
2,627
-153
-6% -$1.55K
ONCT
2290
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$23K ﹤0.01%
1,015
-10
-1% -$223
LTCH
2291
DELISTED
Latch, Inc. Common Stock
LTCH
$22K ﹤0.01%
18,900
+8,130
+75% +$20.8K
ABTS icon
2292
Abits Group
ABTS
$4.09M
$20K ﹤0.01%
1,320
+13
+1% +$256
SNMP
2293
DELISTED
Evolve Transition Infrastructure LP
SNMP
$20K ﹤0.01%
+1,568
New +$24.2K
BLRX
2294
BioLineRX
BLRX
$11.8M
$19K ﹤0.01%
360
-5
-1% -$278
XWEL icon
2295
XWELL
XWEL
$8.66M
$18K ﹤0.01%
1,300
-535
-29% -$9.4K
ASTR
2296
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
$18K ﹤0.01%
+912
New +$37.2K
LVOX
2297
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$18K ﹤0.01%
10,900
+900
+9% +$2.22K
OLOX
2298
Olenox Industries
OLOX
$4.5M
$17K ﹤0.01%
2
– –
ONCS
2299
DELISTED
OncoSec Medical Incorporated
ONCS
$17K ﹤0.01%
1,036
– –
NCMI icon
2300
National CineMedia
NCMI
$378M
$15K ﹤0.01%
+1,679
New +$28.4K
90 91
92
93 94

Similar funds

FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
X
Xponance Philadelphia, Pennsylvania $14.1B AUM 30.11% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $14.1B AUM 19.14% 1-Year Est. Return
TI
Trexquant Investment Stamford, Connecticut $13.9B AUM 31.98% 1-Year Est. Return

Schonfeld Strategic Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Schonfeld Strategic Advisors held 3,357 positions worth $10.3B, down 7.2% from $11.1B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.

Schonfeld Strategic Advisors deployed $969M of net new capital in Q2 2022, opening 810 new positions and adding to 937 existing holdings. Its largest new stake was Nike: 535,587 shares worth $54.7M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was AutoNation, an estimated $61.6M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2022 buy was Nike: 535,587 shares worth $54.7M.
  • Schonfeld Strategic Advisors added most to Intercontinental Exchange in Q2 2022, an estimated $98M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2022 reduction was AutoNation, cutting an estimated $61.6M.
  • Schonfeld Strategic Advisors fully exited RH in Q2 2022, selling an estimated $38.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 9.3% of its $10.3B portfolio in Q2 2022.
  • Schonfeld Strategic Advisors opened 810 new positions and closed 885 in Q2 2022.
  • Schonfeld Strategic Advisors's portfolio value fell 7.2% quarter-over-quarter to $10.3B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.